ED  State of Wisconsin Investment Board

http://www.swib.state.wi.us/





     Office Locations:

121 E. Wilson St.
Madison, WI 53703
Phone: 608-266-2381
Fax: 608-266-2436

 

Stages:

  • Early
  • Expansion
  • Growth
  • Middle Market


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare
  • Software & Internet

  •  

    Description:

    The State of Wisconsin Investment Board (SWIB), created in 1951, is responsible for managing the assets of the Wisconsin Retirement System (WRS), the State Investment Fund (SIF) and other state trust funds. As of December 31, 2020, SWIB managed about $144 billion in assets. SWIB is required to make investment management decisions for the pension funds solely for the benefit of the members of the Wisconsin Retirement System (WRS). Investments in Wisconsin, which follow strict guidelines, are part of SWIB's everyday investment activity in the global markets. SWIB also makes a special effort to identify investment opportunities that exist within the state. There are two portfolios dedicated primarily to Wisconsin investments.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Anne-Marie Fink Chief Investment Officer
    Brandon Brickner Internal Audit Director
    Brian Hellmer Chief Investment Officer
    Edwin Denson Executive Director and Chief Investment Officer
    Jameson Greenfield Chief Financial Officer

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      08/15/2024


      HistoSonics


      


      $102,000,000


      Series D


      01/23/2024


      Elephas Biosciences


      WI


      $55,000,000


      Series C


     

    Portfolio companies include:


      Catalyze.io
        web link


      Chromatin
        web link


      EatStreet
        web link


      Elephas Biosciences
        web link


      FluGen


      HistonSonics
        web link


      HistoSonics


      Madison Vaccines


      Neurovance
        web link


      NeuWave Medical
        web link


      Sittercity
        web link


      Zurex Pharma
        web link


     

    Recent News: